drugset / Trial / NCT00763009

Persantine: Variation in Response Trial

NCT00763009

NaSingle-groupOpen-labelDiagnostic

Summary

The primary objective of this study is to understand why different people respond differently to the medication Persantine. The effects of Persantine will be evaluated by performing echocardiograms, blood tests and by measuring the flow of blood in the arteries of the heart in patients undergoing a clinically indicated percutaneous coronary intervention.

Timeline

Start
2002-09
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dipyridamole Other / unclassified 0.28 mg/kg Intravenous